Iti Pharma and Healthcare Fund
ITI Mutual Fund · FM: Nilay Dalal, Animesh Singh · INF00XX01BO9 · Direct
NAV ₹20.15 AUM ₹252 Cr as of 22 Sep 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:27 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.6% | +1.6% | +7.3% | +24.3% | +13.4% | +21.5% | — | 45/234 | 0.92% |
Equity allocation
96.78%
Non-equity allocation (combined)
3.22%
All Equity Holdings (37) latest available
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 33.6 | 13.34% | — |
| 2 | Divi's Laboratories Ltd | 17.1 | 6.79% | — |
| 3 | Apollo Hospitals Enterprise Ltd | 15.7 | 6.22% | — |
| 4 | Dr Reddy's Laboratories Ltd | 13.7 | 5.44% | — |
| 5 | Max Healthcare Institute Ltd Ordinary Shares | 13.6 | 5.41% | — |
| 6 | Cipla Ltd | 11.6 | 4.60% | — |
| 7 | Torrent Pharmaceuticals Ltd | 11.5 | 4.56% | — |
| 8 | Laurus Labs Ltd | 11.1 | 4.40% | — |
| 9 | Aurobindo Pharma Ltd | 10.3 | 4.10% | — |
| 10 | Lupin Ltd | 8.3 | 3.30% | — |
| 11 | Neuland Laboratories Ltd | 7.8 | 3.09% | — |
| 12 | Fortis Healthcare Ltd | 7.4 | 2.94% | — |
| 13 | Cohance Lifesciences Ltd | 7.3 | 2.89% | — |
| 14 | Mankind Pharma Ltd | 7.2 | 2.84% | — |
| 15 | Alkem Laboratories Ltd | 6.9 | 2.75% | — |
| 16 | Global Health Ltd | 5.1 | 2.01% | — |
| 17 | Abbott India Ltd | 4.6 | 1.82% | — |
| 18 | Aster DM Quality Care Ltd Ordinary Shares | 3.9 | 1.54% | — |
| 19 | Ipca Laboratories Ltd | 3.8 | 1.52% | — |
| 20 | Sai Life Sciences Ltd | 3.3 | 1.30% | — |
| 21 | Poly Medicure Ltd | 3.2 | 1.28% | — |
| 22 | Linde India Ltd | 3.1 | 1.25% | — |
| 23 | Shaily Engineering Plastics Ltd | 3.1 | 1.22% | — |
| 24 | Shilpa Medicare Ltd | 3.0 | 1.18% | — |
| 25 | Piramal Pharma Ltd | 2.9 | 1.14% | — |
| 26 | Glenmark Pharmaceuticals Ltd | 2.8 | 1.12% | — |
| 27 | HealthCare Global Enterprises Ltd | 2.7 | 1.09% | — |
| 28 | Supriya Lifescience Ltd | 2.6 | 1.03% | — |
| 29 | Rainbow Childrens Medicare Ltd | 2.6 | 1.02% | — |
| 30 | Biocon Ltd | 2.5 | 0.97% | — |
| 31 | Venus Pipes & Tubes Ltd | 2.4 | 0.95% | — |
| 32 | GlaxoSmithKline Pharmaceuticals Ltd | 2.3 | 0.90% | — |
| 33 | Zydus Lifesciences Ltd | 1.9 | 0.74% | — |
| 34 | Caplin Point Laboratories Ltd | 1.5 | 0.59% | — |
| 35 | Bharat Dynamics Ltd Ordinary Shares | 1.4 | 0.54% | — |
| 36 | Yes Bank Ltd | 1.3 | 0.51% | — |
| 37 | Syngene International Ltd | 1.0 | 0.39% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.